Invited Commentary re: Comparison of 1% and 3% Polidocanol Foam in Ultrasound Guided Sclerotherapy of the Great Saphenous Vein: A Randomised, Double-blind Trial with 2 Year-Follow-up. "The 3/1 Study".
Cavezzi
A
A
Clinica Stella Maris and Poliambulatorio Hippocrates, Vascular Unit, San Benedetto del Tronto, AP, Italy.
D000328:Adult; D004304:Dosage Forms; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D000077423:Polidocanol; D011092:Polyethylene Glycols / Q000008:administration & dosage*; D011859:Radiography; D016032:Randomized Controlled Trials as Topic; D012501:Saphenous Vein / Q000000981:diagnostic imaging; D012597:Sclerosing Solutions / Q000008:administration & dosage*; D015911:Sclerotherapy / Q000295:instrumentation*; D018084:Ultrasonography, Interventional; D014648:Varicose Veins / Q000000981:diagnostic imaging / Q000628:therapy*
D004304:Dosage Forms; D012597:Sclerosing Solutions; D000077423:Polidocanol; D011092:Polyethylene Glycols